56 related articles for article (PubMed ID: 7510869)
1. Pituitary adenylate cyclase activating polypeptide: a neuropeptide with potent inotropic and coronary vasodilatory effects in neonatal pig hearts.
Ross-Ascuitto NT; Ascuitto RJ; Ramage D; Kydon DW; Coy DH; Kadowitz PJ
Pediatr Res; 1993 Sep; 34(3):323-8. PubMed ID: 7510869
[TBL] [Abstract][Full Text] [Related]
2. Contractile and coronary vascular effects of pituitary adenylate cyclase activating polypeptide in neonatal pig hearts.
Ascuitto RJ; Ross-Ascuitto NT; Waddell AE; Kadowitz PJ
Cardiovasc Res; 1996 Feb; 31 Spec No():E153-9. PubMed ID: 8681340
[TBL] [Abstract][Full Text] [Related]
3. Acetylcholine-induced coronary vasoconstriction and negative inotropy in the neonatal pig heart.
Ascuitto RJ; Ross-Ascuitto NT; Ramage D; McDonough KH; Kadowitz PJ
Pediatr Res; 1992 Aug; 32(2):236-42. PubMed ID: 1508617
[TBL] [Abstract][Full Text] [Related]
4. Pituitary adenylate cyclase activating polypeptide is a potent vasodilator in humans.
Warren JB; Cockcroft JR; Larkin SW; Kajekar R; Macrae A; Ghatei MA; Bloom SR
J Cardiovasc Pharmacol; 1992 Jul; 20(1):83-7. PubMed ID: 1383635
[TBL] [Abstract][Full Text] [Related]
5. Anorexigenic effects of pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal peptide in the chick brain are mediated by corticotrophin-releasing factor.
Tachibana T; Saito ES; Takahashi H; Saito S; Tomonaga S; Boswell T; Furuse M
Regul Pept; 2004 Aug; 120(1-3):99-105. PubMed ID: 15177926
[TBL] [Abstract][Full Text] [Related]
6. Analysis of cardiovascular responses to PACAP-27, PACAP-38, and vasoactive intestinal polypeptide.
Champion HC; Santiago JA; Garrison EA; Cheng DY; Coy DH; Murphy WA; Ascuitto RJ; Ross-Ascuitto NT; McNamara DB; Kadowitz PJ
Ann N Y Acad Sci; 1996 Dec; 805():429-41; discussion 442. PubMed ID: 8993422
[TBL] [Abstract][Full Text] [Related]
7. Pituitary adenylate cyclase-activating polypeptide-27 causes a biphasic chronotropic effect and atrial fibrillation in autonomically decentralized, anesthetized dogs.
Hirose M; Furukawa Y; Nagashima Y; Lakhe M; Chiba S
J Pharmacol Exp Ther; 1997 Nov; 283(2):478-87. PubMed ID: 9353360
[TBL] [Abstract][Full Text] [Related]
8. [Effects of sulfur dioxide on cardiac function of isolated perfusion heart of rat].
Zhang SQ; Du JB; Tian Y; Geng B; Tang CS; Tang XY
Zhonghua Yi Xue Za Zhi; 2008 Mar; 88(12):830-4. PubMed ID: 18756988
[TBL] [Abstract][Full Text] [Related]
9. Calcitonin gene-related peptide and tachykinins in relation to local sensory control of cardiac contractility and coronary vascular tone.
Franco-Cereceda A
Acta Physiol Scand Suppl; 1988; 569():1-63. PubMed ID: 3266056
[TBL] [Abstract][Full Text] [Related]
10. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide enhance IL-10 production by murine macrophages: in vitro and in vivo studies.
Delgado M; Munoz-Elias EJ; Gomariz RP; Ganea D
J Immunol; 1999 Feb; 162(3):1707-16. PubMed ID: 9973433
[TBL] [Abstract][Full Text] [Related]
11. Effects of pituitary adenylate cyclase-activating polypeptide on facial nerve recovery in the Guinea pig.
Kimura H; Kawatani M; Ito E; Ishikawa K
Laryngoscope; 2003 Jun; 113(6):1000-6. PubMed ID: 12782812
[TBL] [Abstract][Full Text] [Related]
12. Analysis of responses to pituitary adenylate cyclase activating polypeptide-38 in the feline hindquarters vascular bed.
Santiago JA; Kadowitz PJ
Eur J Pharmacol; 1993 Oct; 243(3):291-4. PubMed ID: 7903943
[TBL] [Abstract][Full Text] [Related]
13. Effect of pituitary adenylate cyclase-activating polypeptide 38 (PACAP38) on tissue oxygen content--treatment in central nervous system of mice.
Ohtaki H; Dohi K; Yofu S; Nakamachi T; Kudo Y; Endo S; Aruga T; Goto N; Watanabe J; Kikuyama S; Shioda S
Regul Pept; 2004 Dec; 123(1-3):61-7. PubMed ID: 15518894
[TBL] [Abstract][Full Text] [Related]
14. [Effects of amrinone on isolated heart preparations: comparative study with other inotropic agents].
Raddino R; Metra M; Catellani E; Nodari S; Pelà G; Manca C; Dei Cas L
Cardiologia; 1991 Sep; 36(9):729-34. PubMed ID: 1686991
[TBL] [Abstract][Full Text] [Related]
15. Coronary vascular effects of vasoactive intestinal peptide in the isolated perfused rat heart.
Sawmiller DR; Henning RJ; Cuevas J; Dehaven WI; Vesely DL
Neuropeptides; 2004 Oct; 38(5):289-97. PubMed ID: 15464194
[TBL] [Abstract][Full Text] [Related]
16. Effects of proadrenomedullin N-terminal 20 peptide and calcitonin on isolated perfused rat hearts.
Kaygisiz Z; Ozden H; Erkasap N; Köken T; Gündüz T; Ikizler M; Kural T
Anadolu Kardiyol Derg; 2009 Jun; 9(3):176-82. PubMed ID: 19520650
[TBL] [Abstract][Full Text] [Related]
17. The vasoactive peptide maxadilan from sand fly saliva inhibits TNF-alpha and induces IL-6 by mouse macrophages through interaction with the pituitary adenylate cyclase-activating polypeptide (PACAP) receptor.
Soares MB; Titus RG; Shoemaker CB; David JR; Bozza M
J Immunol; 1998 Feb; 160(4):1811-6. PubMed ID: 9469441
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological characterization of VIP and PACAP receptors in the human meningeal and coronary artery.
Chan KY; Baun M; de Vries R; van den Bogaerdt AJ; Dirven CM; Danser AH; Jansen-Olesen I; Olesen J; Villalón CM; MaassenVanDenBrink A; Gupta S
Cephalalgia; 2011 Jan; 31(2):181-9. PubMed ID: 20974589
[TBL] [Abstract][Full Text] [Related]
19. Characterization of ocular receptors for pituitary adenylate cyclase activating polypeptide (PACAP) and their coupling to adenylate cyclase.
Nilsson SF; De Neef P; Robberecht P; Christophe J
Exp Eye Res; 1994 Apr; 58(4):459-67. PubMed ID: 7925682
[TBL] [Abstract][Full Text] [Related]
20. Pituitary adenylate cyclase-activating polypeptide: localization and differential influence on isolated hearts from rats and guinea pigs.
Chang Y; Lawson LJ; Hancock JC; Hoover DB
Regul Pept; 2005 Jul; 129(1-3):139-46. PubMed ID: 15927709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
